PhinC Development is the expert partner for small to medium size pharmaceutical or biotechs companies, who need to move forward in early drug research.
Thanks to a multidisciplinary team with thorough field experience, PhinC Development helps to take the best decisions concerning drug development using all existing pharmacology and pharmacometrics modeling & simulation (M&S) tools.
PhinC Development offers more rapid and efficient solutions than punctual consulting or CROs.
PhinC Development designs and drives all clinical operations (files, protocols, global development strategy) and coordinates all clinical research actors to optimize your drug development from the drug candidate selection to phase IIb (or later). The application of the MBDD concept "Model Based Drug Development" will significantly optimize the development of your drug candidate at different levels:
- Providing essential data on the product under study from the earliest stages of development
- Strengthen scientific justifications during regulatory submissions
- Optimization of time and means to implement
PhinC Development brings you the best MBDD tool at each step to go efficiently to the next step.
- PBPK Physiological Based Pharmacokinetic
- PopPK Population pharmacokinetic
- PKPD Pharmacokinetic/ Pharmacodynamic